METASTASIS
Clinical trials for METASTASIS explained in plain language.
Never miss a new study
Get alerted when new METASTASIS trials appear
Sign up with your email to follow new studies for METASTASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cancer drug THOR-707 trial halted early
Disease control TerminatedThis study tested an experimental drug called THOR-707, alone or with other treatments, in adults with advanced or metastatic solid tumors. The main goals were to find safe doses and see if the drug could shrink tumors. The trial was terminated early, so results are limited.
Matched conditions: METASTASIS
Phase: PHASE1, PHASE2 • Sponsor: Synthorx, Inc, a Sanofi company • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
New MRI dye could spot hidden prostate cancer spread
Diagnosis TerminatedThis study tested whether a special MRI contrast agent called Ferumoxtran-10 (Ferrotran®) can better find prostate cancer that has spread to lymph nodes compared to standard MRI. About 172 men with newly-diagnosed prostate cancer at medium to high risk of spread received an enhan…
Matched conditions: METASTASIS
Phase: PHASE3 • Sponsor: Saving Patients' Lives Medical B.V. • Aim: Diagnosis
Last updated May 17, 2026 00:49 UTC
-
Brain radiation trial for breast cancer halted early
Prevention TerminatedThis study looked at whether giving radiation to the brain early could prevent cancer from spreading there in people with HER2-positive breast cancer that had already spread to other organs. All participants were receiving trastuzumab (Herceptin) plus chemotherapy. The study was …
Matched conditions: METASTASIS
Phase: PHASE3 • Sponsor: Centre Oscar Lambret • Aim: Prevention
Last updated May 17, 2026 00:59 UTC